Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer
Go back to Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 50.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.35 | 52 Week High | $35.13 | |||
| Open | $50.35 | 52 Week Low | $28.10 | |||
| Day High | $50.35 | P/E | N/A | |||
| Day Low | $50.35 | EPS | $0.00 | |||
| Volume | 1 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| Roper Industries (NASDAQ: ROP) | Delayed: 329.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $329.54 | 52 Week High | $195.93 | |||
| Open | $329.54 | 52 Week Low | $155.79 | |||
| Day High | $329.54 | P/E | 61.37 | |||
| Day Low | $329.54 | EPS | $5.37 | |||
| Volume | 101 | |||||
